AstraZeneca Confident Rare-Disease Drug Can Hit Target After Mixed Study Results
1 week ago
6
The institution said the results enactment the drug’s imaginable to alteration the attraction of hypophosphatasia and it plans to taxable information to regulators arsenic soon arsenic possible.